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Abstract 
The study was aimed at evaluating the validity of impact measures among patients with Ménière’s disease (MD) with 
outcome variables of EuroQol generic health-related quality of life (HRQoL) measures (i.e., EQ-5D) by using Visual 
Analogue Scale (VAS) and EQ-5D index values. 183 members (out of 200 contacted) of the Finish Ménière Associa-
tion returned the questionnaires that they had filled out. Various open-ended and structured questionnaires focus-
ing on diagnostic aspects of symptoms and impairment caused by the disease were used. For activity limitation and 
participation restriction, standardized questionnaires were used. Open-ended questions on impact of the disease 
were asked, and subsequently classified based on the WHO-ICF classification. The general HRQoL was evaluated with 
EQ-5D index value and EQ VAS instruments. Correlation and linear regression analyses were used to explore the asso-
ciation between HRQoL and other aspects. Based on the explanatory power of different models the disease specific 
semeionic model provides the most accurate prediction in EQ-5D index calculations (38 % of the variance explained). 
In EQ VAS scores, HRQoL is most accurately determined by participation restriction (53 % of the variance explained), 
but the worst prediction was in ICF-based limitations (8 % of the variance explained). Interestingly, attitude and 
personal trait explained the reduction of HRQoL somewhat better than ICF-based variables. Activity limitation and 
participation restrictions are significant components of MD, but are less frequently recognized as significant factors 
in self-evaluating the effect of MD on the quality of life. The current study results suggest that MD patients seem to 
have problem identifying factors causing activity limitation and participation restrictions and hence use the semiotic 
description focusing on complaints.
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Background
Ménière’s disease (MD) is commonly approached as an 
organ specific disease of the inner ear, and is assessed 
based on vertigo, tinnitus, and hearing loss; although, the 
behavioral restrictions are far more extensive (Orji 2014). 
Considering the diversity of this condition, quantifying 
the impact of disease-related difficulties on measures of 
quality of life (QoL) and health status utility represents a 
continuing challenge to researchers.
QoL is the perceived quality of an individual’s daily life, 
and it can be measured by using standardized instru-
ments. A good QoL in relation to an individual refers to 
a person managing daily life activities and social relation-
ships well (Williams 1985). The health-related quality 
of life (HRQoL) is more specific and is related to physi-
cal, mental, emotional, and social functioning; how-
ever, a health status refers to a holistic concept, which 
is determined by factors which are more than the pres-
ence or absence of any disease. It is often summarized by 
life expectancy or self-assessed health status, and more 
broadly includes indications of functioning, physical ill-
ness, and mental well being. Although the definitions of 
these two constructs are similar, QOL and health status 
are distinct constructs (Smith et  al. 1999). For example, 
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when rating QOL, patients give greater emphasis to men-
tal health than to physical functioning. However, this pat-
tern is reversed for appraisals of health status, for which 
physical functioning is more important than mental 
health (Smith et al. 1999).
The impact of MD can be evaluated by using com-
plaints rated on the basis of severity (Levo et al. 2010), by 
different impairment questionnaires (Levo et al. 2013), or 
by using disease specific measures (Stephens et al. 2010; 
Kato et  al. 2004). Various general measures have been 
used to assess the effect on HRQoL on MD patients (Levo 
et  al. 2012; Anderson and Harris 2001; Soderman et  al. 
2002; Yardley et  al. 2003), but only a few studies have 
explored the factors associated and resulting in reduced 
QoL (Levo et  al. 2012; Anderson and Harris 2001; Kin-
ney et al. 1997). The disease-specific instruments tend to 
be more responsive to psychological states and to symp-
toms of MD, as compared to general health measures 
that focus on broader aspects of the conditions (Kato 
et al. 2004; Levo et al. 2012; Diaz et al. 2007). However, 
the application of general health-related instruments 
may miss clinically significant changes in QoL in a spe-
cific illness because the questions are too broad (Green 
et  al. 2007). Moreover, the QoL measures also seem to 
be influenced by attitude toward the illness, for example, 
positive thinking (Stephens et  al. 2010). Hence, a more 
focused approach may be necessary to understand the 
impact of the disorder.
The World Health Organisation (WHO) has recom-
mended the International Classification of Function-
ing, Disability and Health (ICF) to be used to describe 
the complex association among factors such as impair-
ment, functioning, activity limitations, and participation 
restrictions caused by a disorder on human well-being 
[World Health Organization (WHO) 2001]. To perform 
such analysis in MD, Levo et  al. (2010) used data from 
open-ended questionnaires and classified the impair-
ments with the ICF framework. The prediction of impact 
on QoL was less efficient when using ICF based classifi-
cation when compared to using impairment question-
naires, which delivered somewhat different explanatory 
variables (Levo et  al. 2013; Stephens and Pyykko 2011). 
Also, it is important to note that using the ICF frame-
work may provide much broader understanding of the 
condition’s impact when compared to using disease-spe-
cific instruments.
The EQ-5D is a widely used survey instrument for 
measuring economic preferences for health states. It 
is one of several such instruments that can be used to 
determine the quality-adjusted life years associated with 
a health state. When reporting the general health EQ-
5D-3L (3L—referring to three levels in the response 
scale) results, usually either EQ-5D index value or Visual 
Analogue Scale (EQ VAS) value has been reported. The 
index value and VAS evaluations may differ between sub-
jects due to various reasons as dynamic variations of the 
disease (Bagust and Beale 2005). Other reasons may be 
due to changes in social communication, personal needs, 
and acceptance of the impairment. A better knowledge of 
differences between VAS and EQ-5D index values could 
help in rehabilitation by providing understanding for the 
need of proper enablement procedures to restore the 
quality of life. Moreover, it is also important to under-
stand the relationship between different evaluation 
approaches (e.g., broad vs focused) on the HRQoL.
The aim of the current study was to evaluate the validity 
of impact measures among patients with MD with out-
come variables of EuroQol generic QoL (i.e., EQ-5D-3L) 
measures by using VAS and index value instruments.
Method
Study design and participants
Permission was obtained from the Finnish Ménière Fed-
eration (FMF) to contact their members, asking them to 
complete an extensive questionnaire on symptoms related 
to MD. Under Finnish law, this kind of questionnaire 
study performed in collaboration with patient association 
does not need ethical approval. For this purpose, every 
sixth name on their membership list was taken; thus, a 
sample composed of 200 individuals was contacted. They 
were sent a 26-page questionnaire by mail as in our pre-
vious studies (Stephens et  al. 2010, 2012), together with 
a stamped and addressed envelope for their responses. 
Those not responding within 12 weeks were sent remind-
ers. Every returned questionnaire was examined; if there 
were missing data, the respondent was contacted by tel-
ephone and asked to answer the unanswered questions so 
as to achieve complete data. In total, 186 out of 200 sent 
questionnaires were returned, resulting in a return rate of 
93 %; however, 3 questionnaires had significant amount of 
missing values and were removed. The 183 participants 
had the mean age of 61.5, and there were 36 men and 147 
women in the sample, reflecting the gender spread in FMF.
Questionnaires
The total questionnaire comprised the Vertigo Question-
naire (Kentala 1996), the EQ-5D-3L measure (Rabin and 
de Charro 2001), the International Tinnitus Inventory 
(ITI; Chéry-croze and Collet 2005), The Hearing Disabil-
ity and Handicap Scale (HDHS; Philibert 1994), Localiza-
tion questions based on the Hearing Measurement Scale 
(HMS; Chung and Stephens 1983), a Dizziness Handicap 
Questionnaire (DHQ;  Yardley et  al. 1992), a Participa-
tion Restriction Scale (Stephens 2001), and the Sense of 
Coherence (SOC) Scale-Short version (Antonovsky and 
Sagy 1986). There were also some open-ended questions.
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The specific restriction and function limitation open-
ended question was worded as follows: Please make 
a list of the main effects that your Ménière’s disease has 
on your life. Write down as many as you can think of. In 
this task, five lines were indicated for each subject to fill. 
Thereafter, the items were classified based on ICF classi-
fication [World Health Organization (WHO) 2001]. The 
classification was done independently by two research-
ers. However, four researchers discussed the analysis and 
a consensus was achieved in relation to ICF codes. From 
the 183 subjects, 176 reported some effects of MD that 
resulted in some functional limitation. The classification 
provided 64 different entities belonging to 6 main catego-
ries (Levo et al. 2010).
The individuals were asked to rate the impact of MD 
by asking, “How much does Ménière’s disease influence in 
your life?”. The question was scaled in five steps ranging 
from not at all to very severely. This question was used 
as an outcome measure of disease specific impact of MD 
on life. In addition, the effect of cardinal symptoms on 
MD, as vertigo, gait, hearing, tinnitus, pressure in the ear, 
hyperacusis, and possible other disorders were also rated 
in a five step scale from no effect to very severe effect.
In modelling of impairment related to MD and its 
restrictions, we used EuroQol general health meas-
ure, the EQ-5D. The EQ-5D instrument consists of two 
parts: five questions relating to the distinct dimensions 
of a patient’s functional capacity mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression) 
on each of which 3 responses are possible, and a visual 
analogue scale (VAS) on which the patient is asked to 
indicate a self-rating of their current health state. The 
former are combined with weightings derived from a 
sample of the general European population to provide 
a ‘social tariff ’ EQ-5D index value (Dolan et  al. 1995). 
The latter constitutes a more direct indicator of patients’ 
own implicit preferences. You can find more information 
about the questions and rating scale used in the EQ-5D 
by visiting their website (http://www.euroqol.org/).
Data analysis
The association between EQ-5D-3L and other aspects (e.g., 
symptoms, activity limitations, etc.) was analysed first by 
exploring associations with the Pearson correlation matrix 
and then by using the linear regression analysis method. 
In EQ-5D index value, each state of the five health-related 
dimensions is assigned at the three functional levels of no 
problem, some problem, and extreme problem.
Results
For the whole population, the average EQ-5D index value 
values and EQ VAS values are shown in Table 1. It also 
provides the percentage of study samples in three func-
tional levels in the five dimensions of the EQ-5D.
Figure  1 presents the EQ-5D index value and EQ-5D 
VAS values in the current sample suggesting skewness in 
the EQ-5D index value values, whereas EQ VAS values 
are dominated by an even tenth value in the scale.
When individual scores are aggregated for a popula-
tion sample, the resultant function is inherently nonlin-
ear. Figures  2 demonstrates the EQ-5D index value and 
VAS values of different age groups. In EQ-5D index val-
ues, the effect of age was not significantly dependent on 
age (F = 1.206, p = 0.305). However, in the health score 
evaluation on VAS scale in the age group of 50 years, the 
VAS values differed significantly from older age groups 
(F = 4.401, p < 0.01), with older age groups scoring worse 
VAS values. We therefore standardized the effect of age 
in linear regression analysis when the VAS instrument 
was the outcome variable.
Table 1 The demographic details and summary of EQ-5D quality of life values
Parameter Mean (±SD) Lower range Upper range
Age (in years) 61.5 (10.5) 22 91
Symptom duration (in years) 18.4 (11.1) 1 63
EQ-5D Index value 0.75 (0.19) 0.29 1.0
EQ-5D VAS value 71.2 (17.1) 20 100
No problem Some problem Extreme problem
EQ-5D Dimensions (% of population reporting the problem)
 Mobility 59.6 40.4 0
 Self-care 97.3 3.7 0
 Usual activities 74.3 33.4 3.3
 Pain/discomfort 44.8 50.8 4.4
 Anxiety/depression (mood) 76.5 22.4 1.1
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Internal association of EQ score and its association 
with various symptoms and complaints associated 
with MD
Table  2 presents correlation results of various symp-
toms and components of MD with five dimensions of 
the EQ-5D dimensions. In correlation analysis, motility 
correlated with usual activities (0.55, p < 0.001) and pain 
(r = 0.33, p < 0.001). The mood correlated with self-care 
(0.20, p < 0.001), usual activities (r = 0.25, p < 0.001), and 
pain (r =  0.32, p  <  0.001). The self-care correlated with 
usual activities (r = 0.29, p < 0.001) and mood (r = 0.20, 
p  <  0.001). Only motility was biased by ageing of the 
subjects with older subjects having more problems with 
mobility. Males also had more pain-related complaints 
than females. The duration of disease did not correlate 
with any of the QoL components.
Quality of life measured with ICF oriented approach
Table  3 demonstrates linear regression model with the 
ICF-based limitations when EQ-5D index value and VAS 
are outcome variables. In VAS evaluation, the model 
consisting from vertigo, hearing loss, and a salt-free diet 
was statistically significant (r  =  0.293, p  <  0.001) and 
explained only 8.6 % of variance in VAS. In EQ-5D index 
value model, two variables were significant: impairment 
dietary impact and nausea. Also, this model was statisti-
cally significant (r = 0.257, p < 0.001) and explained 6.6 % 
of variance in EQ-5D index value.
Fig. 1 Distribution of EQ-5D Index values (left) and VAS scores (right) among 183 participants
Fig. 2 Linear regression model outcome of age in EQ-5D index values (left) and VAS scores (right)
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Quality of life measured with symptoms oriented approach
Table 4 demonstrates a linear regression model consisting 
of symptoms when EQ-5D index value and VAS instru-
ments were outcome variables. In VAS evaluation, the 
model consisted of gait problems, balance problems, phys-
ical strain induced vertigo, and shortage of energy. This 
model was statistically significant (r = 0.624, p < 0.001) and 
explained 38.9 % of the variance in VAS. In EQ-5D index 
value model, three variables were significant: impairment 
of gait, balance problems and shortage of energy. Also, this 
model was statistically significant (r  =  0.634, p  <  0.001) 
and explained 37.8 % of the variance in EQ-5D index value. 
Noteworthy was that neither hearing problems nor vertigo 
correlated with quality of life in this study.
Quality of life measured with activity limitations oriented 
approach
For assessment of activity limitations, tinnitus was 
assessed on a ITI questionnaire with 8 questions. The 
functional limitation of hearing was assessed by a ques-
tionnaire consisting of 10 questions. Localization of 
sound was assessed by a sound localization questionnaire 
consisting of 4 questions. The vertigo was evaluated with 
a vertigo handicap questionnaire consisting of 8 ques-
tions. A total of 24 questions were analyzed.
Table 5 presents the linear stepwise regression analysis 
of factors describing activity limitations in MD on VAS 
and EQ-5D index based measures of 5D QoL. The VAS 
instrument based model consisted of two vertigo linked 
variables (walking on the sidewalk, bending provoked ver-
tigo, and activity limitation by fear of having an attack), 
one tinnitus related variable (frequency of unbearable 
tinnitus), and one hearing linked variable (problems of 
hearing a doorbell). The model was statistically significant 
(r = 0.622, p < 0.001) and explained 38.7 % of the variance 
in VAS. The EQ-5D index value could be explained by ver-
tigo-linked variables (temporary activity limitations and 
walking in open space), and one tinnitus linked variable 
Table 2 Correlation of EQ-5D components with various aspects of the Ménière’s disease including symptoms of the dis-
ease, activity limitations and participation restrictions, personal traits, and attitude
*p ≤ 0.05; **p ≤ 0.01
Motility Self-care Usual activities Pain Mood
Vertigo severity n.s. 0.19* n.s. n.s. n.s.
Nausea AND vomiting n.s. 0.15* n.s. n.s. n.s.
Tumarkin attack 0.184* n.s. 0.252** 0.216** n.s.
Balance problems 0.496** n.s. 0.451** 0.258** n.s.
Unsteadiness 0.506** 0.198** 0.514** 0.321** n.s.
Moving ability 0.559** 0.357** 0.446** 0.386** n.s.
Chair rise 0.442** 0.271** 0.381** 0.350** 0.176*
Impact of vertigo 0.249** 0.158* 0.272** 0.236** n.s.
Tinnitus impact 0.156* n.s. n.s. 0.125 n.s.
Balance impact 0.569** 0.327** 0.433** 0.371** 0.225**
Hearing impact n.s. n.s. n.s. n.s. n.s.
Pressure impact 0.226** 0.229** 0.214** 0.198**
Anxiety/nervousness 0.181* n.s. 0.219** 0.214** 0.349**
Energetics/fatigue 0.286** 0.159* 0.356** 0.344** 0.316**
Sense of coherence −0.185* −0.182* −0.264** −0.272** −0.417**
Table 3 Linear stepwise regression analysis of ICF-based limitations by the Ménière’s disease with EQ-5D VAS and EQ-5D 
index values as outcome variables
Variable VAS model, r = 0.293 EQ-5D index value model, r = 0.293
Coeff S.E. P Coeff S.E. P
Constant 69.1 1.7 <0.001 0.78 0.02 <0.001
Vertigo −7.6 2.9 0.010 n.s n.s 0.168
Hearing 6.9 3.9 0.012 n.s n.s 0.192
Diet 0.7 4.2 0.022 n.s n.s 0.996
Nausea n.s n.s 0.543 −0.13 0.07 0.011
Drugs n.s n.s 0.161 0.22 0.05 0.003
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(frequency of unbearable tinnitus). The model was sta-
tistically significant (r =  0.558, p < 0.001) and explained 
29.6 % of the variance in EQ-5D index value.
Quality of life measured with participation restrictions 
oriented approach
The questionnaire focuses on participation restrictions 
(consisting of 30 questions) caused by health condition on 
conversations, traveling, shopping, traveling to medical 
appointments, banks and offices, attending learning cir-
cles, relationship to others, work related activities,among 
others. Table  6 presents the linear stepwise regres-
sion analysis of factors describing participation restric-
tion in MD on VAS and EQ-5D index based measures 
of 5D QoL. In VAS based model of quality of life, six 
variables turned out to be indicative (see Table  6). The 
model was statistically significant (r = 0.580, p < 0.001) 
and explained 33.7 % of VAS variability. In EQ-5D index 
value based model, only three variables were included in 
the model that was statistically significant (r  =  0.457). 
EQ-5D index value, p < 0.001) could explain 17.3 % of the 
variability of EQ-5D index value. In factorial analysis, the 
participation restriction consisted of 7 factors covering 
68  % of the data. Broadly, the variables associated with 
VAS-measure consisted of communication, listening, 
daily activities, social activity, and learning restrictions. 
The EQ-5D index value associated variables consisted of 
restrictions in social activity and in daily activity. In VAS 
measure the hearing impairment associated restrictions 
dominated, whereas in EQ-5D index value the participa-
tion restriction consisted mainly from balance impair-
ment associated problems.
The difference between EQ-5D index value and VAS 
measurement
Table 7 presents the summary from the feasibility of dif-
ferent parameter descriptions in the evaluation general 
HRQoL with EQ-5D index value and VAS instruments. 
For comparison, a model consisting of personal traits 
measured with SOC and self-rated anxiety is included. 
Based on the explanatory power of different models, 
it seems that the disease symptom specific semeionic 
model provides the most accurate prediction in EQ-5D 
index value calculations (37.8 %). In VAS scores, QoL is 
most accurately determined by participation restriction 
(53.3 %). The worst prediction in both EQ-5D index value 
and VAS models was in ICF-based limitations (5.6 and 
7.9  % respectively). Interestingly enough, attitude and 
personal traits explained the reduction of QoL somewhat 
better than the ICF-based variables.
Discussion
The aim of the present study was to evaluate the valid-
ity of impact measures among patients with MD with 
Table 4 Linear stepwise regression analysis of symptoms of the Ménière’s disease with EQ-5D VAS and EQ-5D index val-
ues as outcome variables
Variable VAS model, r = 0.624 EQ-5D index value model, r = 0.558
Coeff SE P Coeff SE P
Constant 84.8 1.8 <0.001 0.90 0.02 <0.001
Balance −3.8 1.6 0.017 −0.26 0.11 0.019
Gait −7.6 2.1 <0.001 −0.79 0. 14 <0.001
Physical strain −3.3 1.3 0.013 n.s. n.s. 0.879
Energy −2.5 1.3 0.048 −0.06 0.01 <0.001
Table 5 Linear stepwise regression analysis of  factors describing activity limitations caused by  the Ménière’s disease 
with EQ-5D VAS and EQ-5D index values as outcome variables
Variable VAS model, r = 0.622 EQ-5D index model, r = 0.558
Coeff SE P Coeff SE P
Constant 91.8 2.9 <0.001 0.94 0.03 <0.001
Problems with gait on sidewalk −6.8 1.6 <0.001 −0.05 0.02 <0.032
Unbearable tinnitus occurrence −3.9 1.1 0.001 −0.04 0.02 0.020
Bending provoking vertigo −7.4 1.7 <0.001 -0.05 0.02 0.006
Hearing door bell ringing −3.1 1.3 <0.05 n.s. n.s. 0.522
Activity limitation (e.g., shopping) caused by vertigo n.s. n.s. 0.144 −0.071 0.022 0.002
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outcome variables of EuroQol generic QoL. Further-
more, differences between two generic health evaluation 
methods in EQ-5D (EQ-5D index value and VAS) were 
explored. We found that the symptom profile of the dis-
ease provided the major outcome in generic HRQoL. 
The VAS instrument had seemingly an inherent prop-
erty to include age-associated changes in performance 
as well as in attitude and personal trait. If these vari-
ables were added in the VAS-instrument that contained 
the symptom profile, the regression (38.9–39.2  %) did 
not significantly improve. In contrast, the EQ-5D index 
value -instrument was markedly improved by attitude 
and personal trait (i.e., 37.8–45.3  %). As these meas-
ures are not within the EQ-5D index value –instrument, 
the VAS-instrument provides different aspects of QoL 
in MD, which can be missed if only one instrument is 
inspected. The attitudes towards the disease and per-
sonal trait played a minor role in the estimation of QoL 
in MD, which is consistent with results from previous 
studies by Levo et  al. (2012) and Stephens et  al. (2010). 
Vigor and energy are not normally explored in relation 
to MD, although the patient often complains about a 
lack of energy (Stephens et al. 2010). This variable could 
partly explain the reduction in QoL, and the difference in 
EQ-5D index value and VAS scaling methods. Values and 
value judgments are intrinsic to measurements of this 
sort and need to be made explicit. The results confirm 
the previous observation that there is a shortage of rel-
evant and validated questionnaires assessing the impact 
of vertigo or dizziness on generic QoL (Duracinsky et al. 
2007).
Correlation analysis indicated that mood (e.g., anxiety/
depression) was related to very few aspects of complaints 
and symptoms, whereas the other four dimensions of 
the EQ-5D (mobility, self-care, usual activities and pain) 
were associated with more complaints and symptoms of 
MD (see Table  2). In addition, various internal correla-
tions were observed (e.g., motility correlated with usual 
activities and pain; mood correlated with self-care, usual 
activities, and pain; self-care correlated with usual activi-
ties and mood). Moreover, some age and gender effects 
were also noticed, although the duration of the disease 
Table 6 Linear stepwise regression analysis of factors describing participation restrictions caused by the Ménière’s dis-
ease with EQ-5D VAS and EQ-5D index values as outcome variables
Variable VAS model, r = 0.580 EQ-5D index model, r = 0.457
Coeff S.E. P Coeff S.E. P
Constant 109.7 4.04 <0.001 0.89 0.07 <0.001
Participating in lectures −5.16 1.66 0.007 n.s. n.s. 0.968
Restriction on performing household tasks −5.50 1.89 0.036 −0.114 0.03 <0.001
Hearing quiet conversation −5.38 1.92 0.006 n.s. n.s. 0.444
Problems in visiting doctor −6.22 2.15 0.005 n.s. n.s. 0.917
Loss of interest in watching TV −5.78 1.91 0.003 n.s. n.s. 0.734
Restriction on relationships to close people by hearing problem 8.22 2.23 <0.000 n.s. n.s. 0.40
Restriction on visiting close people by hearing problem −6.74 1.90 0.001 n.s. n.s. 0.223
Traveling alone n.s. n.s. 0.547 −0.34 0.02 0.059
Problems staying home alone n.s. n.s. 0.633 0.138 0.62 0.029
Table 7 Goodness of  fit models describing health related quality of  life with  EQ-5D index value and  VAS instruments 
when evaluated with ICF-based limitations, symptom specific complaints, activity limitations, and participation restric-
tions variables
For comparison, attitude and personal trait measures are included
Measurable VAS (%) EQ-5D index value (%) Ménière impact (%)
ICF-based limitations 8.6 7.9 8.7
Symptoms 38.9 34.2 48.3
Activity limitations 38.7 32.1 47.2
Participation restrictions 33.7 17.3 53.4
Attitude and personal trait 8.8 22.7 23.4
Symptoms, attitude and personal trait 39.2 44.8 51.1
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does not seem to be related to any of the QoL compo-
nents. These observations provide useful information for 
clinicians in management and rehabilitation planning of 
MD patients. This indicates that learning to cope with the 
disease (Kentala et al. 2013) does not necessarily improve 
QoL as has been suggested (Tyrrell et al. 2015).
In the present study, the individuals with MD tend to 
evaluate their health with a symptoms based approach 
rather than with the limitation of function. Control of 
symptoms may be a more understandable way to improve 
the QoL and influence the instrument values when com-
pared to the effects of limitations and various restrictions 
experienced by the patient. In this respect, our observa-
tions confirm the concept that condition specific symp-
tom measures that mirror treatment or condition of 
certain illness have high acceptability and relevance for 
patients and doctors (Kind 2001). They also can be influ-
enced by treatment, and are sensitive to change. In the 
therapeutic process, interest has therefore been focused 
to change the medical factors reducing the EQ-5D index 
value and VAS scores. However, as indicated in the pre-
sent study, not all the items are related to medical con-
ditions. Some of the VAS and EQ-5D index value scores 
are linked to personal trait and attitude. Personal trait 
is, however, resistant to changes as SOC is difficult to 
change in adult subjects. However, possibly some attitude 
dependent variables in activity limitation and participa-
tion restriction can be influenced by therapy as shortage 
of energy, ability to drive a car, capability to do shopping, 
and the uncertainty with management at work. If medi-
cal conditions cannot be alleviated, then the rehabilita-
tive efforts might be focused on these domains in order 
to improve accessibility and remove hindrances. One 
such effort is a peer support system, involving patient-to-
patient help, and also support from significant others can 
be enhanced.
The WHO-ICF is a multipurpose classification 
designed to serve various disabilities and health con-
ditions [World Health Organization (WHO) 2001]. It 
specifically aims to provide a scientific basis of under-
standing through studying health and health related 
status, outcomes and determinants. ICF can be used as 
an explanatory framework that may allow more com-
prehensive understanding of the character of illness, 
and how it may be described and potentially alleviated 
(Wade and Halligan 2003). The ICF provides a patient-
centered illness description that may provide useful 
insights into finding solutions to overcome the impact 
of the condition. It was, therefore, interesting to study 
the applicability of ICF to be used in a model describ-
ing QoL. With EQ-5D index value and VAS value, the 
ICF based limitations provides the possibility to exam-
ine differences from patients’ perspectives and compare 
them with the perspectives of the observer. Although 
the VAS and EQ-5D index value based models yielded 
rather poor explanatory power (8  %), the limitations 
loaded partly differently into the EQ-5D index and VAS 
models. The poor performance in connection with QoL 
instruments may be due to two factors: (1) patients had 
problems identifying items limiting their activities when 
asked open-ended questions; or (2) alternatively they 
had adapted to their current situations and had thus not 
identified existing problems if not specified by a ques-
tionnaire. The former option might occur due to tempo-
rary changes in the disease, as patients tend to focus on 
more recent symptoms. The latter option would occur 
if the measures of QoL would reflect other aspects of 
the illness as, for example, own will that is not directly 
described in ICF-classification. Both of these aspects 
may be true and should be evaluated in further stud-
ies. One way of doing that might be to understand how 
the ICF-based approach will relate to QoL measures 
when used with open-ended and structured question-
naires. However, the current study results indicate that 
the patients were not able to identify the crucial factors 
describing the illness, or that illness has more dimen-
sions than defined by ICF.
In MD, the VAS values seem to contain additional 
items that will confound the evaluation of the impact of 
the disease. Such confounders in the present study were 
mood, attitude, expectations of progress of the disease, 
and ageing among others. We also observed that VAS 
includes some important items as cognitive ability, mem-
ory, vitality, and a large scale of social restrictions that 
were not met in EQ-5D index value -instrument. In MD, 
the EQ-5D index value measures complaint associated 
reduction of activity, and is adapted to the ageing pro-
cess. The EQ-5D index value and VAS are measuring thus 
somewhat different dimensions of the impact on gen-
eral HRQoL in MD. The ICF-based items described by 
the patients did not contain elements that could explain 
reduction of QoL in the present study. This seems to be 
due to heterogeneous responses of the patients exhibiting 
a large scale of different topics in their replies.
Conclusions
The current study suggests that a more focused symp-
tom oriented approach is more sensitive in relation to 
general HRQoL, whereas the more comprehensive ICF-
based approach explained less variance. The study iden-
tified differences between VAS and EQ-5D index value, 
indicating that they may assist in understanding different 
aspects of QoL. Overall, these findings suggest that MD 
patients seem to have problems identifying factors caus-
ing activity limitation and participation restrictions and 
use the semiotic description focusing on complaints.
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